US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Veradermics, Inc.

102.82

-2.5000-2.37%

Post-market: 102.820.00000.00%19:30 EDT

Volume:393.62K

Turnover:41.10M

Market Cap:4.30B

PE:-15.96

High:108.87

Open:105.18

Low:102.52

Close:105.32

52wk High:131.24

52wk Low:32.00

Shares:41.78M

Float Shares:26.54M

Volume Ratio:0.64

T/O Rate:1.48%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-6.4439

EPS(LYR):-111.9114

ROE:-72.06%

ROA:-43.45%

PB:5.28

PE(LYR):-0.92

Loading ...

Overview Company News Filings

Veradermics Inc - Announces Upsized Public Offering of 3,843,790 Shares at $100.00 per Share

THOMSON REUTERS

Veradermics Hair Loss Trial Success Spurs Funding Plans For VDPHL01

Simply Wall St.

BUZZ-U.S. STOCKS ON THE MOVE-Enterprise Products, Sherwin-Williams, Veradermics

Stock Track | Veradermics Soars 5.55% Intraday After Citigroup Raises Target Price to $120

BUZZ-Veradermics falls after launching follow-on stock sale

Veradermics announces offering of 3.35M shares of common stock

Veradermics launches public offering of 3,350,000 common shares, pre-funded warrants

Veradermics Announces Launch of Public Offering

THOMSON REUTERS

Veradermics Inc: Has Launched Proposed Public Offering of 3.4 Mln Shares of Common Stock

THOMSON REUTERS

Veradermics files to sell 3.35M shares of common stock

Small U.S. Stocks Finish Mixed As Veradermics Leads, POET Technologies Lags

Veradermics price target raised to $120 from $85 at Citi

Buy Rating Reiterated as Strong VDPHL01 Data De-Risk Program and Drive Price Target Increase to $120

Top Midday Gainers

MT Newswires Live

BUZZ-U.S. STOCKS ON THE MOVE-Domino's Pizza, Veradermics, Peloton

BUZZ-Absci rises as brokerage highlights growing opportunity in hair‑loss market

Veradermics Reports Positive Phase 2/3 Data for VDPHL01

BUZZ-Veradermics jumps after experimental oral hair loss pill posts positive late‑stage trial results

Veradermics Shares Gain on Positive Data from Hair Loss Treatment Study

A new version of an old drug is helping men grow back some of their hair

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/MANE/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MANE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MANE\",,,,,undefined,":{"symbol":"MANE","market":"US","secType":"STK","nameCN":"Veradermics, Inc.","latestPrice":102.82,"timestamp":1787342400000,"preClose":105.32,"halted":0,"volume":393617,"hourTrading":{"tag":"盘后","latestPrice":102.82,"preClose":102.82,"latestTime":"19:30 EDT","volume":10632,"amount":1093288.29,"timestamp":1787355006654,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.02373718192176225,"floatShares":26539200,"shares":41778687,"eps":-6.443948,"marketStatus":"Market Closed","change":-2.5,"latestTime":"08-21 16:00:00 EDT","open":105.18,"high":108.87,"low":102.52,"amount":41101845.331470005,"amplitude":0.060292,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-6.443948,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"listingDate":1770181200000,"exchange":"NYSE","adjPreClose":105.32,"preHourTrading":{"tag":"盘前","latestPrice":104,"preClose":105.32,"latestTime":"09:10 EDT","volume":179,"amount":18787.939524,"timestamp":1787317853011,"change":-1.32,"changeRate":-0.012533,"amplitude":0.040733},"postHourTrading":{"tag":"盘后","latestPrice":102.82,"preClose":102.82,"latestTime":"19:30 EDT","volume":10632,"amount":1093288.29,"timestamp":1787355006654,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.6367700717110018,"impliedVol":0.9649,"impliedVolPercentile":0.3929},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MANE\",,,,,undefined,":{"symbol":"MANE","floatShares":26539200,"roa":"-43.45%","roe":"-72.06%","lyrEps":-111.911419,"volumeRatio":0.6367700717110018,"shares":41778687,"dividePrice":0,"high":108.87,"amplitude":0.060292,"preClose":105.32,"low":102.52,"week52Low":32,"pbRate":"5.28","week52High":131.2399,"institutionHeld":0,"latestPrice":102.82,"eps":-6.443948,"divideRate":0,"volume":393617,"delay":0,"ttmEps":-6.443948,"open":105.18,"prevYearClose":17,"prevWeekClose":112.71,"prevMonthClose":105,"prevQuarterClose":122.94,"fiveDayClose":112.71,"twentyDayClose":109.51,"sixtyDayClose":100.13},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MANE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-11","symbol":"MANE","fiscalQuarterEnding":"2026/06","expectedEps":-0.58,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786420800000,"reportTimeType":"pre","actualEps":-0.58}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MANE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MANE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4286,"buy":0.5714,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5714,"analysts":7,"updateTime":1784174400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MANE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MANE","date":"2026-08-21","current":-15.956057,"percent":0.50365,"low":-67.545361,"twenty":-54.602336,"median":-47.561116,"eighty":-33.713665,"high":-9.296992,"avg":-45.298569,"sd":11.240682,"marketCap":4400283923},"quantilePoints":[{"date":"2026-02-06","current":-25.786263,"twenty":-25.079893,"median":-17.8457,"eighty":-10.368249,"marketCap":1387507243},{"date":"2026-02-13","current":-30.838039,"twenty":-29.065754,"median":-25.786263,"eighty":-19.198356,"marketCap":1659333205},{"date":"2026-02-20","current":-33.530469,"twenty":-32.062123,"median":-28.069277,"eighty":-25.043809,"marketCap":1804207481},{"date":"2026-02-27","current":-29.776333,"twenty":-31.085076,"median":-29.967163,"eighty":-25.732137,"marketCap":1602204947},{"date":"2026-03-06","current":-33.738647,"twenty":-32.654736,"median":-30.560469,"eighty":-26.152655,"marketCap":1815409101},{"date":"2026-03-13","current":-35.785726,"twenty":-33.721993,"median":-31.049686,"eighty":-27.249057,"marketCap":1925558357},{"date":"2026-03-20","current":-39.491287,"twenty":-35.53175,"median":-31.816474,"eighty":-28.546698,"marketCap":2124947181},{"date":"2026-03-27","current":-46.874652,"twenty":-39.507941,"median":-32.867771,"eighty":-29.468231,"marketCap":2522231279},{"date":"2026-04-02","current":-31.356106,"twenty":-39.513493,"median":-32.867771,"eighty":-29.852665,"marketCap":2194770608},{"date":"2026-04-10","current":-31.99758,"twenty":-38.92088,"median":-32.857362,"eighty":-30.17702,"marketCap":2239670594},{"date":"2026-04-17","current":-39.540857,"twenty":-39.536494,"median":-33.608872,"eighty":-30.279902,"marketCap":2767662294},{"date":"2026-04-24","current":-36.942854,"twenty":-39.536494,"median":-33.738647,"eighty":-30.421684,"marketCap":2585815082},{"date":"2026-05-01","current":-52.813611,"twenty":-40.831905,"median":-34.49692,"eighty":-30.615983,"marketCap":3696688710},{"date":"2026-05-08","current":-63.45616,"twenty":-42.963163,"median":-35.411007,"eighty":-30.844978,"marketCap":4441613943},{"date":"2026-05-15","current":-51.496667,"twenty":-46.59847,"median":-35.988193,"eighty":-30.890717,"marketCap":4368307751},{"date":"2026-05-22","current":-50.831536,"twenty":-50.412067,"median":-36.702792,"eighty":-31.015444,"marketCap":4311886693},{"date":"2026-05-29","current":-50.670085,"twenty":-50.670085,"median":-37.508333,"eighty":-31.226637,"marketCap":4298191318},{"date":"2026-06-05","current":-49.857433,"twenty":-50.482929,"median":-39.295461,"eighty":-31.282151,"marketCap":4229256485},{"date":"2026-06-12","current":-46.493546,"twenty":-50.049515,"median":-39.519044,"eighty":-31.356106,"marketCap":3943908052},{"date":"2026-06-18","current":-45.24748,"twenty":-50.006173,"median":-40.004977,"eighty":-31.7244,"marketCap":3838207974},{"date":"2026-06-26","current":-58.79168,"twenty":-50.634624,"median":-40.906894,"eighty":-31.961359,"marketCap":4987121867},{"date":"2026-07-02","current":-63.278505,"twenty":-51.067836,"median":-42.661209,"eighty":-32.20951,"marketCap":5367725705},{"date":"2026-07-10","current":-61.520221,"twenty":-53.048338,"median":-44.057315,"eighty":-32.416525,"marketCap":5218575793},{"date":"2026-07-17","current":-52.123009,"twenty":-54.2625,"median":-44.976596,"eighty":-32.698555,"marketCap":4421438445},{"date":"2026-07-24","current":-57.062948,"twenty":-54.490042,"median":-45.472923,"eighty":-32.869852,"marketCap":4840478675},{"date":"2026-07-31","current":-51.531989,"twenty":-54.856474,"median":-45.794173,"eighty":-33.139095,"marketCap":4371304020},{"date":"2026-08-07","current":-53.511905,"twenty":-54.832834,"median":-46.684099,"eighty":-33.593192,"marketCap":4539254342},{"date":"2026-08-14","current":-50.036631,"twenty":-54.832834,"median":-47.316049,"eighty":-33.69117,"marketCap":4637595096},{"date":"2026-08-21","current":-47.476198,"twenty":-54.602336,"median":-47.561116,"eighty":-33.713665,"marketCap":4400283923}],"updateTime":1787503333794},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MANE\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2631029572","title":"Veradermics Inc - Announces Upsized Public Offering of 3,843,790 Shares at $100.00 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2631029572","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631029572?lang=en_us&edition=fundamental","pubTime":"2026-04-30 10:32","pubTimestamp":1777516320,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nTUA7DTMQR:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MANE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631058274","title":"Veradermics Hair Loss Trial Success Spurs Funding Plans For VDPHL01","url":"https://stock-news.laohu8.com/highlight/detail?id=2631058274","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631058274?lang=en_us&edition=fundamental","pubTime":"2026-04-29 01:03","pubTimestamp":1777395801,"startTime":"0","endTime":"0","summary":"Veradermics (NYSE:MANE) reported positive topline data from its pivotal Phase 2/3 trial of VDPHL01, an investigational non-hormonal oral treatment for pattern hair loss.\nThe company framed VDPHL01 as a potential first in class oral option that could lead to the first FDA approval for a non-hormonal hair loss pill in nearly 30 years.\nFollowing the clinical update, Veradermics launched a proposed public offering tied to this stage of clinical and corporate progress.\n\nVeradermics focuses on...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-mane/veradermics/news/veradermics-hair-loss-trial-success-spurs-funding-plans-for","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-mane/veradermics/news/veradermics-hair-loss-trial-success-spurs-funding-plans-for","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MANE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630758913","title":"BUZZ-U.S. STOCKS ON THE MOVE-Enterprise Products, Sherwin-Williams, Veradermics","url":"https://stock-news.laohu8.com/highlight/detail?id=2630758913","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630758913?lang=en_us&edition=fundamental","pubTime":"2026-04-28 23:39","pubTimestamp":1777390791,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Enterprise Products, Sherwin-Williams, VeradermicsWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning N","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nL6N41B15S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MUU","CVX","ZBH","AXGN","SANM","CNC","AMUU","KMB","OXY","RMBS","HLT","UPS","ALLE","NEM","NVD2.UK","SHW","DT","MU","AMD","JBLU","AMGN","LFST","ERAS","XOMO","XOMX","XOMZ","UGI","XOM","APA","ARM","SBUX","SNVD.UK","GM","NVDA","SFD","SPOT","NVDS.UK","SBU","MANE","ORCL","MUD","CLYM","UHS","BBBY","ANV","DPZ","EPD","GLW","ORCU","KO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183431036","title":"Stock Track | Veradermics Soars 5.55% Intraday After Citigroup Raises Target Price to $120","url":"https://stock-news.laohu8.com/highlight/detail?id=1183431036","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183431036?lang=en_us&edition=fundamental","pubTime":"2026-04-28 22:25","pubTimestamp":1777386344,"startTime":"0","endTime":"0","summary":"Veradermics, Inc. (MANE) saw its stock price soar 5.55% during intraday trading on Tuesday, reflecting strong investor interest in the pharmaceutical company.The surge follows an analyst upgrade from...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630334381","title":"BUZZ-Veradermics falls after launching follow-on stock sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2630334381","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630334381?lang=en_us&edition=fundamental","pubTime":"2026-04-28 05:42","pubTimestamp":1777326142,"startTime":"0","endTime":"0","summary":"BUZZ-Veradermics falls after launching follow-on stock sale** Shares of hair-restoration drug developer Veradermics MANE.N fall 3.6% to $96.50 in extended trading** MANE kicks off follow-on public offering of 3.35 million shares/pre-funded warrants; MANE had gone public in New York in February after upsized $256.3 million IPO. ** Concurrently with the offering, MANE expects to enter securities purchase agreement with certain entities affiliated with Suvretta Capital in a private placement. ** Stock closed up 47.6% on Monday at $100.10, roughly six times its IPO price of $17** MANE earlier on Monday reported positive latestage trial results for its experimental oral drug for pattern hair loss** Jefferies, Leerink Partners, Citigroup and Cantor acting as joint bookrunning managers for follow-on offering ** All four brokerages covering the stock rate it \"buy\" or higher; median PT is $85 - data compiled by LSEG** MANE will have 40.7 million outstanding shares after the offering, according ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nL4N41A226:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1366192091.USD","LU2462157665.USD","MNSH","LU2125154935.USD","LU0162691827.USD","LU0106831901.USD","LU1506573853.SGD","BK4534","LU1201861249.SGD","LU1244550221.USD","LU0128525689.USD","BK4207","LU0477156953.USD","LU1244550494.USD","LU2236285917.USD","LU2360032135.SGD","MANE","LU0130102774.USD","LU1267930227.SGD","LU2125154778.USD","LU0310800965.SGD","BK4504","BK4007","LU0098860793.USD","LU1162221912.USD","LU0648001328.SGD","LU0052756011.USD","LU0980610538.SGD","LU2417539215.USD","LU0130517989.USD","BK4585","LU2456880835.USD","LU1244550577.SGD","LU0170899867.USD","LU1668664300.SGD","LU1791807156.HKD","IE00BSNM7G36.USD","LU0072461881.USD","LU0320765646.SGD","LU0314106906.USD","BK4566","BK4588","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630343823","title":"Veradermics announces offering of 3.35M shares of common stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2630343823","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630343823?lang=en_us&edition=fundamental","pubTime":"2026-04-28 05:30","pubTimestamp":1777325415,"startTime":"0","endTime":"0","summary":"Veradermics (MANE) announced that it has launched a proposed public offering of 3.35M shares of common stock pursuant to a registration statement f...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/veradermics-announces-offering-of-3-35m-shares-of-common-stock-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/veradermics-announces-offering-of-3-35m-shares-of-common-stock-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630834824","title":"Veradermics launches public offering of 3,350,000 common shares, pre-funded warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2630834824","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630834824?lang=en_us&edition=fundamental","pubTime":"2026-04-28 05:26","pubTimestamp":1777325184,"startTime":"0","endTime":"0","summary":"Veradermics launched proposed public offering of 3,350,000 shares of common stock, with pre-funded warrants offered in lieu of common stock to certain investors.Underwriters hold 30-day option to buy up to 502,500 additional shares.Company expects to enter securities purchase agreement to sell pre-funded warrants to entities affiliated with Suvretta Capital in a private placement.Public offering size will be reduced one-for-one for each pre-funded warrant sold in private placement, keeping total issuance at 3,350,000 securities.Jefferies, Leerink Partners, Citigroup, Cantor named joint bookrunners, with LifeSci as passive bookrunner.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Veradermics Inc. published the original content used to ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nNDL83ZNjk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BSNM7G36.USD","LU1162221912.USD","LU1244550494.USD","BK4207","BK4566","LU0072461881.USD","MANE","LU2456880835.USD","LU0106831901.USD","BK4007","LU0314106906.USD","LU0980610538.SGD","LU1244550577.SGD","LU1267930227.SGD","LU2125154778.USD","LU0320765646.SGD","BK4534","LU0130517989.USD","MNSH","LU0648001328.SGD","LU1366192091.USD","LU0128525689.USD","BK4504","LU2236285917.USD","BK4588","BK4585","LU0098860793.USD","LU2360032135.SGD","BK4559","LU0052756011.USD","LU2462157665.USD","LU0477156953.USD","LU1201861249.SGD","LU1668664300.SGD","LU0170899867.USD","LU2417539215.USD","LU1791807156.HKD","LU2125154935.USD","LU1244550221.USD","LU1506573853.SGD","LU0310800965.SGD","LU0162691827.USD","LU0130102774.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630482253","title":"Veradermics Announces Launch of Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2630482253","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630482253?lang=en_us&edition=fundamental","pubTime":"2026-04-28 05:26","pubTimestamp":1777325160,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nTUA6LZZQM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MANE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630348216","title":"Veradermics Inc: Has Launched Proposed Public Offering of 3.4 Mln Shares of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2630348216","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630348216?lang=en_us&edition=fundamental","pubTime":"2026-04-28 05:26","pubTimestamp":1777325160,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nTUA6LZZQM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MANE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630343386","title":"Veradermics files to sell 3.35M shares of common stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2630343386","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630343386?lang=en_us&edition=fundamental","pubTime":"2026-04-28 05:20","pubTimestamp":1777324843,"startTime":"0","endTime":"0","summary":"17:19 EDT Veradermics (MANE) files to sell 3.35M shares of common stock Published first on TheFly – the ultimate source for real-time, market-movin...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/veradermics-files-to-sell-3-35m-shares-of-common-stock-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/veradermics-files-to-sell-3-35m-shares-of-common-stock-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MANE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630317234","title":"Small U.S. Stocks Finish Mixed As Veradermics Leads, POET Technologies Lags","url":"https://stock-news.laohu8.com/highlight/detail?id=2630317234","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630317234?lang=en_us&edition=fundamental","pubTime":"2026-04-28 04:21","pubTimestamp":1777321260,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of small-cap companies were mixed Monday, as the Russell 2000 Index closed flat, and the S&P Small Cap 600 Index was up 0.1%.Among companies with a market value of $1 billion to $6.7 billion, Veradermics Inc. was the best performer during the session, surging 48%, followed by Critical Metals Corp., which jumped 26%. Organon & Co. shares surged 17%, United States Antimony Corp. surged 15%, and shares of AEVEX Corp. Cl A jumped 14%.POET Technologies Inc. was the biggest laggard, dropping 47%, followed by shares of MaxLinear Inc., which dropped 14%. Shares of Willdan Group Inc. dropped 14%, PDF Solutions Inc. shares plunged 11%, and Erasca Inc. plunged 11%.Major U.S. stock indexes ended Monday mixed as the Nasdaq Composite Index increased 0.2%. Meanwhile, the S&P 500 Index added 0.1%, and the Dow Jones Industrial Average declined 0.1%.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4141","POET","MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630146543","title":"Veradermics price target raised to $120 from $85 at Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2630146543","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630146543?lang=en_us&edition=fundamental","pubTime":"2026-04-28 02:46","pubTimestamp":1777315581,"startTime":"0","endTime":"0","summary":"Citi raised the firm’s price target on Veradermics (MANE) to $120 from $85 and keeps a Buy rating on the shares after the company announced positiv...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/veradermics-price-target-raised-to-120-from-85-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/veradermics-price-target-raised-to-120-from-85-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630146323","title":"Buy Rating Reiterated as Strong VDPHL01 Data De-Risk Program and Drive Price Target Increase to $120","url":"https://stock-news.laohu8.com/highlight/detail?id=2630146323","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630146323?lang=en_us&edition=fundamental","pubTime":"2026-04-28 02:45","pubTimestamp":1777315522,"startTime":"0","endTime":"0","summary":"Geoff Meacham, an analyst from Citi, maintained the Buy rating on Veradermics, Incorporated. The associated price target was raised to $120.00. Geo...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-reiterated-as-strong-vdphl01-data-de-risk-program-and-drive-price-target-increase-to-120-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-reiterated-as-strong-vdphl01-data-de-risk-program-and-drive-price-target-increase-to-120-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MANE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630113053","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2630113053","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630113053?lang=en_us&edition=fundamental","pubTime":"2026-04-28 02:01","pubTimestamp":1777312877,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences (SGMT) said Monday it has priced an underwritten offering of about 29.2 million shares at $6.00 each to raise about $175 million to help fund its clinical trial.Shares soared 43% a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ORKA","BK4139","MANE","SGMT","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630231132","title":"BUZZ-U.S. STOCKS ON THE MOVE-Domino's Pizza, Veradermics, Peloton","url":"https://stock-news.laohu8.com/highlight/detail?id=2630231132","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630231132?lang=en_us&edition=fundamental","pubTime":"2026-04-28 02:00","pubTimestamp":1777312821,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Domino's Pizza, Veradermics, Peloton Workspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call news","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nL6N41A0MJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289960550.SGD","SPOG","LU1989772840.SGD","LU1267930490.SGD","LU2272731600.USD","LU1935042215.USD","SGXZ23171101.USD","LU1244550221.USD","LU1162221912.USD","LU0943347566.SGD","LU1804176565.USD","LU2097344357.USD","IE00BMPRXR70.SGD","BK4612","LU2750360641.GBP","SG9999017495.SGD","LU0109391861.USD","LU2089283258.USD","LU0889565833.HKD","BK4575","LU1989763005.USD","LU2271345857.HKD","QCML","LU1228905540.USD","LU0323240290.USD","LU2326559502.SGD","LU0316494557.USD","LU1852331112.SGD","IE00BVYPNP33.GBP","IE0005OL40V9.USD","BK4566","LU0823421416.USD","IE00B1XK9C88.USD","LU0719512351.SGD","LU1153585028.USD","LU2100268510.USD","LU0323591593.USD","BK4587","LU0471298777.SGD","LU2250418816.HKD","IE00BJJMRX11.SGD","LU2279689827.SGD","LU0726765562.USD","LU0823434583.USD","BK4114","LU2505996681.GBP","LU1116320901.HKD","LU1670710661.SGD","IE00BKDWB100.SGD","LU1303367103.USD","LU0306806265.USD","BK4085","LU0081259029.USD","LU1261432733.SGD","BK4141","LU1674673428.USD","SG9999015978.USD","LU0198837287.USD","LU2125909593.SGD","SG9999014542.SGD","LU0965509283.SGD","LU1235294995.USD","LU2324357040.USD","LU0432979614.USD","LU0957808578.USD","BK4592","IE0009356076.USD","LU1989764748.USD","LU2065170008.USD","LU2048586759.USD","LU2023250843.SGD","BK4504","LU0820561909.HKD","LU2506952097.USD","LU0345774391.USD","LU1623119135.USD","LU0109394709.USD","LU0960925559.SGD","LU1496350502.SGD","LU0210533765.USD","LU0203347892.USD","LU0267386448.USD","LU0823434740.USD","LU2720916845.USD","LU0823416689.USD","LU0690374961.EUR","SG9999014898.SGD","IE00BHPRN162.USD","DPZ","LU0154236417.USD","BK0028","IE00BFTCPJ56.SGD","LU0265550359.USD","LU1585245621.USD","LU0708995401.HKD","LU0256863902.USD","LU0289739343.SGD","LU0061474960.USD","LU0274383776.USD","LU2362541513.USD","IE00BDCRKT87.USD","LU2210150020.SGD","LU0444971666.USD","LU1951198990.SGD","SG9999013999.USD","LU2430703251.USD","LLYZ","BK4021","BK4598","LU1066051811.HKD","IE00B4JS1V06.HKD","BK4576","LU1582987597.SGD","LU2290526834.HKD","LU0256863811.USD","BK4553","LU2249611893.SGD","SG9999014914.USD","LU1721428933.USD","LU1181866309.USD","LU2133065610.SGD","LU2404859741.USD","GB00B4LPDJ14.GBP","IE00BQXX3C00.GBP","LU2896262040.SGD","LU1400636491.USD","LU2491050154.USD","HK0000819398.USD","LU2931357623.SGD","LU0006061336.USD","LU0417517546.SGD","IE00B7SZLL34.SGD","LU0545562505.USD","LU1732799900.SGD","IE00BJJMRZ35.SGD","LU0070302665.USD","BK4567","LU1878469433.USD","LU2452424414.USD","CRMU","LU1670628061.USD","MSFL","LU2471134952.CNY","LU2065169927.USD","LU0912757837.SGD","BK0012","LU0823417653.USD","LU2242650005.HKD","LU0879622024.SGD","MSFY","LU0054578231.USD","LU0545039389.USD","LU2168564222.USD","LU1861215975.USD","IE0034235295.USD","LU0048584097.USD","BK4585","LU1564329032.USD","LU2097829019.USD","SG9999001176.SGD","LU1934455277.USD","LU1720051017.SGD","BK4189","LU2092627202.USD","IE00B7KXQ091.USD","SG9999004303.SGD","SGXZ81514606.USD","LU0784385170.HKD","LU1196500208.SGD","BK4115","BK4524","LU1778281490.HKD","LU0353189680.USD","LU0234572021.USD","LU2552382132.HKD","IE00BKVL7J92.USD","BK4161","LU1992135472.HKD","LU1697837992.HKD","SG9999015986.USD","LU0097036916.USD","LU0127658192.USD","QCMD","LU2362540622.SGD","BK4604","LU1645745479.HKD","LU0082616367.USD","BK4079","SG9999002232.USD","LU2272731782.SGD","LU2471134796.USD","BK4213","LU0757359368.USD","LU0889565916.HKD","LU1894683348.USD","LU0158827781.USD","LU2456880835.USD","LU1267930813.SGD","LU0950375773.USD","LU0289941410.SGD","LU0963586101.USD","IE00B775SV38.USD","BK4168","LU0314104364.USD","LU0724617625.USD","LU1718418525.SGD","LU1340139317.AUD","LU0511384066.AUD","LU0784385840.USD","LU1861214812.USD","LU0942090050.USD","LU1334329650.SGD","LU2506951792.HKD","LU0323239441.USD","LU0820562030.AUD","LU2487616109.SGD","LU2237443622.USD","SG9999014567.USD","IE00BN29S564.USD","IE00BJJMRY28.SGD","SG9999014880.SGD","LU0208291251.USD","IE00BLSP4239.USD","LU0444973449.USD","LU0210528500.USD","LU1668664300.SGD","LU0557290698.USD","LU1235295455.SGD","LU0170899867.USD","LU0823414551.USD","LU1983260115.SGD","LU2148611432.USD","LU2347655156.SGD","IE00B19Z9505.USD","LU0211328371.USD","IE00BFXG0V08.USD","BK4599","IE000YTNTUN2.SGD","LU2265009873.SGD","SG9999000418.SGD","BK4551","IE0034390439.USD","LU0158827948.USD","LU2491049909.HKD","LU2272731865.HKD","LU0795875169.SGD","LU2191332357.HKD","IE0003U64NQ7.SGD","IE00BQXX3F31.USD","LU0265550946.USD","BK4516","IE0004445015.USD","LU2764263039.SGD","LU2023250504.SGD","LU1582986359.USD","LU0882574139.USD","MVLL","LU2242649171.HKD","BK4008","IE0002141913.USD","LU1621768206.USD","LU2237443382.USD","IE000KEQY171.SGD","MUU","LU1803068623.USD","BK4538","LU0289961442.SGD","LU2275660780.HKD","BK4204","LU1093756168.USD","LU0215105999.USD","LU2746668974.SGD","LU1244550577.SGD","IE00BYQQ9H92.USD","BK4109","LU0882574055.USD","SGXZ51526630.SGD","LU0757359954.USD","IE00B4R5TH58.HKD","TERG","LU1435385759.SGD","LU0114720955.EUR","LU0211326755.USD","IE00B19Z8W00.USD","LU1815333072.USD","LU0784383803.USD","LU1267930573.SGD","LU2112291526.USD","LU0203202063.USD","ELIL","LU1169590202.USD","LU2468319806.SGD","BK4608","LU0672654240.SGD","IE00BLSP4452.SGD","LU2247934214.USD","LU0354030511.USD","LU0321505439.SGD","LU0124676726.USD","LU1861558580.USD","LU2505996509.AUD","LU2237443978.SGD","SNXX","LU2506951875.HKD","LU1236620750.USD","BK4512","LU0320765059.SGD","LU1839511570.USD","LU0203201768.USD","BK4550","ADBG","LU2237438978.USD","LU1043141123.HKD","SG9999001077.SGD","LU0553294199.USD","LU2317271919.USD","LU0308772762.SGD","LU0971096721.USD","LU2381873111.SGD","LU2065171402.SGD","LU2360106780.USD","LU2506951958.HKD","LU2602419157.SGD","LU0456855351.SGD","IE00BFSS8Q28.SGD","LU0238689110.USD","LU1046421795.USD","LU2463028550.USD","LU2028103732.USD","LU0965508806.USD","LU0106831901.USD","LU1989764664.SGD","BK4209","LU2092937148.SGD","LU2210149790.SGD","BK4515","LU1037948897.HKD","LU1564329628.SGD","BK4134","LU2087625088.SGD","IE0009355771.USD","LU2286300806.USD","LU1548497426.USD","LU1582987324.SGD","LU2361044949.HKD","LU0345774631.USD","LU1032466523.USD","ALBG","LU1202635105.USD","LU0312595415.SGD","LU2098885051.SGD","LU1992135399.USD","LU2746668461.USD","LU1621768115.EUR","LU0871640123.AUD","LU2054465674.USD","LU0171293334.USD","LU1429558221.USD","LU1084165304.USD","LU0868494708.USD","LU1035773651.USD","LU0175139822.USD","LU2750360997.AUD","BK4007","LU0345768153.USD","IE00BWXC8680.SGD","LU0784384876.USD","LU2089985449.USD","LU0211327993.USD","LLYX","GB00BDT5M118.USD","BK4532","LU2430703095.HKD","BK4207","IE00B19Z8X17.USD","IE00B19Z3581.USD","LU0056508442.USD","LU1861219969.SGD","LU2095319765.USD","LU1868836591.USD","LU2237443895.HKD","IE00B5TLWC47.USD","LU1400636574.HKD","LU0689472784.USD","LU1732800096.USD","BK4139","LU0096362180.USD","LU1037948541.HKD","LU0342679015.USD","LU0466842654.USD","LU0128525929.USD","IE00BMPRXN33.USD","LU2413666699.HKD","LU0894486033.HKD","LU1074936037.SGD","IE00BGHQDM52.EUR","LU0320765489.SGD","IE00BVYPNQ40.USD","LU0354030438.USD","LU1430594728.SGD","LU1301847155.USD","MSFX","LU2471134879.HKD","BK4116","BK4525","LU0109392836.USD","BK4605","LU0006306889.USD","LU2471134523.USD","IE00B19Z3B42.SGD","IE0009G5SDU7.USD","LU0225283273.USD","LU2111349929.HKD","LU1363072403.SGD","LU2433249047.HKD","LU1236620834.HKD","LU0133085943.USD","LU1291159041.SGD","LU2041044095.USD","LU2360106947.USD","LU1868836757.USD","LU1642822529.SGD","LU1670711040.USD","LU0426412945.USD","LU2413666426.HKD","LU2087621335.USD","LU1551013425.SGD","LU0345770993.USD","LU0642271901.SGD","SGXZ57979304.SGD","LU2360108059.USD","LU2244417387.USD","MUD","LU1935042488.USD","LU1629891620.HKD","BK4155","MSFU","LU0162691827.USD","LU1691799644.USD","LU2106854487.HKD","LU0390134368.USD","LU0211326839.USD","LU1720051108.HKD","LU1791710400.SGD","LU1868836914.USD","LU0426417589.USD","GB00B4QBRK32.GBP","LU2089284900.SGD","LU2764263203.CNY","LU1861127337.USD","LU1791710582.SGD","LU2384288077.EUR","LU2347655073.USD","BK4573","LU0957791311.USD","LU1043141396.HKD","LU0096364046.USD","IE00BN0W2T93.GBP","BK7095","LLII","LU0985320562.USD","LU0661504455.SGD","IE00BJTD4N35.SGD","SGXZ31699556.SGD","LU1169589451.USD","LU0738911758.USD","LU0174119429.USD","IE00BFSS7M15.SGD","LU2168564065.EUR","IE00BQXX3D17.EUR","LU1934455863.HKD","LU1119994496.HKD","LU2168563687.JPY","LU0057025933.USD","LU2461242641.AUD","BK4561","BK4581","BK4543","LU2077746001.SGD","IE00B775H168.HKD","LU0347712357.USD","LU1145028129.USD","LU1989773731.SGD","LU2756315318.SGD","JPO","LU0385154629.USD","MANE","LU0306807586.USD","LU2023250330.USD","BK4113","LU1551013342.USD","LU2458330243.SGD","SG9999018865.SGD","LU2089984988.USD","LU0314106906.USD","LU0157215616.USD","LU0894485498.HKD","LU1280957306.USD","HK0000914660.USD","LU1670627923.USD","LU2361045086.USD","IE00BJT1NW94.SGD","BK7504","LU0683600562.USD","LU2237957811.SGD","MSFD","LU1066053197.SGD","LU2491050071.SGD","IE00BMPRXQ63.HKD","LU0786609619.USD","LU1983299246.USD","LU1564329461.SGD","LU0345768740.USD","LU1400636657.SGD","LU0053666078.USD","LU1868837136.USD","BK4023","LU1923623000.USD","LU2361044865.SGD","BK4190","LU0266013472.USD","LU0708994859.HKD","LU1267930730.SGD","LU0138981039.USD","LU1814569148.SGD","LU1323610961.USD","LU0225771236.USD","LU2211815571.USD","LU2552382215.SGD","LU0077335932.USD","LU0203345920.USD","IE0034235303.USD","IE00BBT3K403.USD","LU2360107168.USD","LU2764262908.HKD","LU2506952170.USD","LU2097344431.USD","LU0149725797.USD","LU0994945656.USD","SG9999014575.USD","IE00BJLML261.HKD","ELIS","LU2404859667.USD","LU1032955483.USD","LU2168564495.EUR","BK4554","IE00BFXG1179.USD","LU0106261372.USD","LU0211331839.USD","LU0321505868.SGD","LU0823421333.USD","LU1670711123.USD","IE00B1BXHZ80.USD","SG9999014559.SGD","LU2213496289.HKD","LU0310800379.SGD","LU2023251221.USD","LU0949170426.SGD","LU1232071149.USD","LU2462591350.SGD","LU2322448791.USD","LU1127390331.HKD","LU2168564149.EUR","IE00BN8TJ469.HKD","BK4108","LU0107464264.USD","LU1121112475.USD","LU1066051225.USD","MSFW","IE0004091025.USD","LU2125154935.USD","LU2417539215.USD","BK4545","BK4559","LU0472753341.HKD","LU1934455194.USD","LU0095938881.EUR","LU1951200564.SGD","IE00B2B36J28.USD","LU1496350171.SGD","LU1803068979.SGD","LU2298321311.HKD","LU0823417737.USD","MULL","BK4527","LU0061474705.USD","LU0823414478.USD","BK4588","IE00BN0W2W23.USD","LU0320765992.SGD","BK4577","LU1815336760.USD","LU1935043023.USD","LU0792757196.USD","LU0689626769.HKD","LU2294711713.HKD","LU1221951129.SGD","LU0011850046.USD","BK4535","SG9999002224.SGD","BK4533","LU1974910355.USD","LU2357125470.USD","LU0289739699.SGD","LU1935042991.SGD","BK4170","LU2083900584.USD","LU0965509010.AUD","LU2322448957.HKD","LU2108987350.USD","LU0251132253.USD","SG9999014906.USD","IE0034235188.USD","IE00BYXW3230.USD","LU0494093205.USD","LU0320765646.SGD","LU2047632596.USD","LU2430703178.SGD","LU2125909247.SGD","LU0868494617.USD","BK4571","SG9999015952.SGD","IE0004086264.USD","SG9999001424.SGD","BK0046","BK4097","LU1221951046.USD","IE00B3S45H60.SGD","LU2236285917.USD","LU2592432038.USD","LU0861579265.USD","LU0788109477.HKD","IE00BN0W2V16.EUR","SG9999015341.SGD","LU0122379950.USD","LU2756315664.SGD","HK0000914686.HKD","LU2403377893.USD","LU1564329115.USD","SG9999015358.SGD","LU2357627491.SGD","LU1366192091.USD","SG9999018857.SGD","LU2543165471.USD","BK4534","LU1621767810.EUR","LU1633808545.USD","LU1023059063.AUD","LU0058720904.USD","LU2360032135.SGD","LU0965509101.SGD","LU0072462426.USD","LU1988902786.USD","LU0353189763.USD","BK4548","LU0471298694.HKD","LU1093756325.SGD","LU1506573853.SGD","IE000M9KFDE8.USD","LU0949170772.SGD","LU1861220033.SGD","LU2063271972.USD","LU0690374615.EUR","IE00BK4W5M84.HKD","LU0094547139.USD","LU0098860793.USD","LU1712237335.SGD","LU2237957902.USD","LU0310799852.SGD","LU0348723411.USD","LU0889566641.SGD","IE00BJTD4V19.USD","IE00B5949003.HKD","LU0079474960.USD","LU1064131342.USD","IE00BSNM7G36.USD","LU0234570918.USD","LU0302445910.USD","LU2125154778.USD","LU1670756490.USD","IE00B4YYXB79.USD","MRVU","LU1228905037.USD","LU2362541273.HKD","LU0345770308.USD","IE00BKPKM429.USD","LU1059921491.USD","IE0004445239.USD","LU1003077747.HKD","LU0795875086.SGD","IE0002270589.USD","LU0069063385.USD","LU0072461881.USD","LU1823568750.SGD","LU1674673691.USD","LU1894683264.USD","LU2473716301.USD","LU0985481810.HKD","LU1069347547.HKD","IE00B19Z6F94.USD","HK0000532082.HKD","LU1366333091.USD","QCMU","BK4143","CRMX","IE000W1ABFV2.USD","LU1868837300.USD","LU1935043536.SGD","LU1621767737.EUR","LU2264538146.SGD","LU2237443549.SGD","LU0187121727.USD","LU1571399168.USD","LU0080751232.USD","LU0976567544.SGD","LU2420271590.USD","LU0345769631.USD","LU1316542783.SGD","BK4579","LU0496365809.HKD","LU1914381329.SGD","BK4528","LU0859254822.USD","LU2458330169.SGD","LU1035775433.USD","LU1188199696.SGD","LU2860962120.EUR","JPMO","LU1244550494.USD","LU2065171311.SGD","LU2357305700.SGD","MSFO","LU2462157665.USD","LU0345769128.USD","LU0640476718.USD","LU0964807845.USD","LU1989772923.USD","LU0528227936.USD","PTON","IE00BDRTCR15.USD","LU1699723380.USD","IE00B3SWFQ91.USD","LU1989771016.USD","IE00BZ1G4Q59.USD","LU1917777945.USD","LU1861559042.SGD","LU0061475181.USD","LU0276348264.USD","LU1582986433.USD","LU1670710588.SGD","LU1923622614.USD","BK4147","LU1066051498.USD","SG9999001176.USD","BK4503","LU2092937221.SGD","IE0001KFT4U8.USD","LU1057294990.SGD","LU0029864427.USD","LU1069344957.HKD","IE00BK4W5L77.USD","LU2552382058.USD","LU0787776722.HKD","BK0239","LU0225284248.USD","LU2237443465.HKD","SG9999015945.SGD","LU3102509885.SGD","LU0070217475.USD","SGXZ99366536.SGD","IE000ITXATA3.USD","LU0210536198.USD","LU1116320737.USD","LU0820561818.USD","LU0476273544.USD","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630731520","title":"BUZZ-Absci rises as brokerage highlights growing opportunity in hair‑loss market","url":"https://stock-news.laohu8.com/highlight/detail?id=2630731520","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630731520?lang=en_us&edition=fundamental","pubTime":"2026-04-28 00:15","pubTimestamp":1777306525,"startTime":"0","endTime":"0","summary":"BUZZ-Absci rises as brokerage highlights growing opportunity in hairloss market** Shares of AI-based drug developer Absci Corp ABSI.O rise 15.2% to $4.54 in early trading** Brokerage KeyBanc says positive mid-to-late stage data from rival Veradermics MANE.N for its oral hair-loss pill reinforce the view that the hair-loss market is sizable and can support multiple therapies** Estimates a more than $40 bln market opportunity for hair-loss treatments and reiterates a $9 price target on Absci** Shares of peer biotech firm Veradermics jump 37.3% to $93.72, Nektar up ~1% to $92.17** Brokerage says Absci's experimental hair-growth drug ABS-201 could complement rather than compete with existing treatments citing its infrequent dosing of two to three injections over six months** Renewed investor interest in hair-loss therapies follows Nektar Therapeutics' NKTR.O update last week that its experimental injection stimulated hair regrowth in patients with alopecia areata, a patchy hair-loss condit","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nL4N41A1KB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NKTR","MANE","BK4139","BK4007","BK4121","ABSI","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630392069","title":"Veradermics Reports Positive Phase 2/3 Data for VDPHL01","url":"https://stock-news.laohu8.com/highlight/detail?id=2630392069","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630392069?lang=en_us&edition=fundamental","pubTime":"2026-04-27 21:32","pubTimestamp":1777296745,"startTime":"0","endTime":"0","summary":"Veradermics, Incorporated ( ($MANE) ) has provided an announcement. On April 27, 2026, Veradermics reported positive topline results from Part A of...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/veradermics-reports-positive-phase-2-3-data-for-vdphl01?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/veradermics-reports-positive-phase-2-3-data-for-vdphl01?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MANE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630395018","title":"BUZZ-Veradermics jumps after experimental oral hair loss pill posts positive late‑stage trial results","url":"https://stock-news.laohu8.com/highlight/detail?id=2630395018","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630395018?lang=en_us&edition=fundamental","pubTime":"2026-04-27 19:53","pubTimestamp":1777290827,"startTime":"0","endTime":"0","summary":"BUZZ-Veradermics jumps after experimental oral hair loss pill posts positive latestage trial results** Shares of biotech firm Veradermics MANE.N jump 25% to $84.84 premarket** Co says it reported positive latestage trial results for its experimental oral drug for pattern hair loss** Says its pill VDPHL01 targets male pattern hair loss, a common condition in which men gradually lose scalp hair due to genetics and hormones** Says the sixmonth study in more than 500 men showed patients on the drug gained over 30 hairs per square cm versus seven on placebo** Adds that nearly 80% of patients on VDPHL01 reported improvement, compared with about 36% on placebo, with benefits seen as early as two months** Says the pill is a nonhormonal, extendedrelease version of minoxidil and showed no serious heartrelated safety issues** Says it plans further studies, including trials in women, with more results expected in 2026** As of last close, stock flat YTD  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nL4N41A11O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630539541","title":"Veradermics Shares Gain on Positive Data from Hair Loss Treatment Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2630539541","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630539541?lang=en_us&edition=fundamental","pubTime":"2026-04-27 19:45","pubTimestamp":1777290300,"startTime":"0","endTime":"0","summary":"Shares of Veradermics climbed after the company shared what it called positive data from a recent trial of its in-development therapy for pattern hair loss.The stock rose 16%, to $79.01, in premarket trading Monday. The stock had its public debut in February, with Veradermics pricing its initial offering of 15.1 million shares at $17 apiece.The biopharmaceutical company said data from a Phase 2/3 clinical trial of the drug, VDPHL01, positions it to become the first Food and Drug Administration-approved oral pill in nearly 30 years for pattern hair loss, as well as a potential best-in-indication treatment option.The recent trial of the treatment met all primary and all key secondary endpoints with statistical significance, demonstrating robust increases in hair count while being generally well tolerated, Veradermics said.Nearly 80% of patients in the once-daily dose arm and 86% of patients in the twice-daily dose arm reported improvement in hair coverage after six months of treatment wi","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MANE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630739824","title":"A new version of an old drug is helping men grow back some of their hair","url":"https://stock-news.laohu8.com/highlight/detail?id=2630739824","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630739824?lang=en_us&edition=fundamental","pubTime":"2026-04-27 19:03","pubTimestamp":1777287780,"startTime":"0","endTime":"0","summary":"Veradermics is developing an extended-release version of oral minoxidil. Veradermics is testing an extended-release formulation of oral minoxidil  in clinical trials.A safer - and more effective - formulation of a popular hair-loss treatment led to robust hair growth in a later-stage clinical trial.Veradermics is working on an extended-release version of oral minoxidil that is thought to reduce the heart palpitations and low blood pressure that can occur when people take higher doses of a minoxidil pill. Minoxidil has the same ingredient as Rogaine, which is available topically over the counter. It's also often prescribed off-label as a pill but can't be taken orally in high doses because of those cardiovascular risks.This is where Veradermics comes in. On Monday, the company announced the first batch of late-stage data that showed solid results for its extended-release minoxidil pill. Veradermics' stock  rallied 16.9% in premarket trade.There is another drug called finasteride that wo","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MANE"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":5,"totalSize":124,"code":"91000000","status":"200"}]}}